Hygromycin A
   HOME

TheInfoList



OR:

Hygromycin A (also known as totomycin) is a modified cinnamic acid flanked by a furanose sugar and aminocyclitol (not to be confused with hygromycin B, belonging to an unrelated class of antibiotics, aminoglycosides). It is produced by '' Streptomyces hygroscopicus'', first described in the 1950s.


History

Hygromycin A was discovered in a soil sample from a forest near Indianapolis, Indiana in 1953 by Waksman and Henrici. Identification and structure of totomycin was not determined until 1957. Little further research was performed on totomycin for decades afterwards due to its weak activity against most bacteria, and as of 2021 its safety or efficacy in humans have not been assessed in any preclinical or clinical trials, although some initial results in mice were promising.


Antibiotic activity

It was thought that the strongest antibiotic activity of totomycin was against '' Staphylococcus haemolyticus'', in which growth was inhibited by concentrations of 2 µg/mL. Other gram-positive and gram-negative sensitive to totomycin are inhibited by concentrations from 16 to 31 µg/mL. In 2021 it was reported that Hygromycin A is very effective against
spirochete A spirochaete () or spirochete is a member of the phylum Spirochaetota (), (synonym Spirochaetes) which contains distinctive diderm (double-membrane) gram-negative bacteria, most of which have long, helically coiled (corkscrew-shaped or s ...
s and can be used to eliminate the spirochete that causes
Lyme disease Lyme disease, also known as Lyme borreliosis, is a vector-borne disease caused by the ''Borrelia'' bacterium, which is spread by ticks in the genus ''Ixodes''. The most common sign of infection is an expanding red rash, known as erythema migran ...
. Bait laced with hygromycin A could be used to eliminate Lyme disease in the wild.


Total synthesis

Totomycin has been a successful target in
total synthesis Total synthesis is the complete chemical synthesis of a complex molecule, often a natural product, from simple, commercially-available precursors. It usually refers to a process not involving the aid of biological processes, which distinguishes i ...
since 1989.


References

{{AminoglycosideAntiBiotics Aminoglycoside antibiotics